CLOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Monitor Medical Inc

Monitor Medical Inc is a Stafford, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Infectio Diagnostic (I.D. L)

Infectio Diagnostic (I.D. L), Inc. is a Quí©bec, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

MediTech Media

MediTech Media, Ltd is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Falck

Falck A/S is a Nordic-based organization with activities in most areas of Europe and representation on five continents.

barre3

Find a barre3® studio near you or subscribe to barre3 Online and start an online workout today.